MOUNTAIN VIEW, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended September 30, 2023 and provided…Read More
IRIDEX Corporation Iridex Reports Third Quarter 2023 Financial Results and Business Update
